Serum Her2 extracellular domain (ECD) levels, pAkt and pMAPK expressions as potential markers for response to trastuzumab(T)-based therapy in metastatic breast cancer (MBC) patients (PTS). A Turkish oncology group study

Basaran G. A., Guney N., Saip P., Iyikesici S., Kaya H., Yazici H., ...More

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Turkey, 29 September - 03 October 2006, vol.17, pp.90-91, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 17
• City: İstanbul
• Country: Turkey
• Page Numbers: pp.90-91
• Istanbul University Affiliated: Yes